A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis

por Mendaza, Saioa, Guerrero-Setas, David, Monreal-Santesteban, Iñaki, Ulazia-Garmendia, Ane, Cordoba Iturriagagoitia, Alicia, De la Cruz, Susana, Martín-Sánchez, Esperanza
Publicado 2021

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

por Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, Vicente-García, Francisco, Blanco-Luquin, Idoia, De La Cruz, Susana, Aramendia, Ana, Guerrero-Setas, David
Publicado 2017

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer

por Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, de Azúa, Yerani Ruiz, Aguiar, Begoña, Beloqui, Raquel, Armendáriz, Pedro, Arriola, Marta, Martín-Sánchez, Esperanza, Guerrero-Setas, David
Publicado 2020

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer

por Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Blanco-Luquin, Idoia, Córdoba, Alicia, Vicente-García, Francisco, Pérez-Janices, Noemí, Escors, David, Megías, Diego, López-Serra, Paula, Esteller, Manel, Illarramendi, José Juan, Guerrero-Setas, David
Publicado 2017